中国全科医学
中國全科醫學
중국전과의학
CHINESE GENERAL PRACTICE
2014年
35期
4245-4247
,共3页
雷振东%邱泽亮%雷李美%黄丽央%陈铃%应项尖%陈雪峰
雷振東%邱澤亮%雷李美%黃麗央%陳鈴%應項尖%陳雪峰
뢰진동%구택량%뢰리미%황려앙%진령%응항첨%진설봉
降钙素原%肺疾病,慢性阻塞性%抗菌药
降鈣素原%肺疾病,慢性阻塞性%抗菌藥
강개소원%폐질병,만성조새성%항균약
Procalcitonin%Pulmonary disease,chronic obstructive%Anti-bacterial agents
目的:探讨降钙素原(PCT)水平检测对慢性阻塞性肺疾病(COPD)急性加重患者选用抗菌药物的指导价值,为COPD急性加重患者选用抗菌药物提供参考。方法选取2012年1月—2014年2月在丽水市莲都区人民医院内科、急诊综合科因COPD急性加重入院患者250例,入院后立即检查PCT。按照PCT水平分为3组,A组( n=48):入院PCT<0.10μg/L,不予抗菌药物;B组(n=72):发病时间<6 h内PCT<0.10μg/L或入院PCT为0.10~0.25μg/L,予观察,隔日检测PCT,若隔日PCT>0.25μg/L,治疗措施同C组;C组( n=130):入院PCT>0.25μg/L,予抗菌药物治疗,同时连续监测PCT,每天下降幅度≥30%说明抗感染治疗有效,PCT正常后停用抗菌药物;如果PCT下降幅度<30%,或持续升高则调整抗菌治疗方案,并每日检测PCT。对比分析3组患者的临床资料、实验室检查指标及预后。结果3组患者的病史、临床症状、病情程度及实验室检查指标比较,差异均有统计学意义(P<0.05)。A组未予抗菌药物治疗;B组予观察,隔日检测PCT,其中40例(55.6%) PCT>0.25μg/L者应用抗菌药物治疗病情好转,32例(44.4%)<0.25μg/L者未应用抗菌药物;C组予抗菌药物治疗,其中30例(23.1%)咳嗽、咳痰、呼吸困难未好转,更改抗菌药物治疗,最终122例预后较好,6例转上级医院,2例分别在住院第5、6天死亡。结论 COPD急性加重患者PCT水平升高者炎性反应及病情严重,基层医院可依据PCT水平判断是否存在炎性反应及病情程度,可以将PCT水平作为选用、更改抗菌药物或评估抗菌药物疗效的参考工具。
目的:探討降鈣素原(PCT)水平檢測對慢性阻塞性肺疾病(COPD)急性加重患者選用抗菌藥物的指導價值,為COPD急性加重患者選用抗菌藥物提供參攷。方法選取2012年1月—2014年2月在麗水市蓮都區人民醫院內科、急診綜閤科因COPD急性加重入院患者250例,入院後立即檢查PCT。按照PCT水平分為3組,A組( n=48):入院PCT<0.10μg/L,不予抗菌藥物;B組(n=72):髮病時間<6 h內PCT<0.10μg/L或入院PCT為0.10~0.25μg/L,予觀察,隔日檢測PCT,若隔日PCT>0.25μg/L,治療措施同C組;C組( n=130):入院PCT>0.25μg/L,予抗菌藥物治療,同時連續鑑測PCT,每天下降幅度≥30%說明抗感染治療有效,PCT正常後停用抗菌藥物;如果PCT下降幅度<30%,或持續升高則調整抗菌治療方案,併每日檢測PCT。對比分析3組患者的臨床資料、實驗室檢查指標及預後。結果3組患者的病史、臨床癥狀、病情程度及實驗室檢查指標比較,差異均有統計學意義(P<0.05)。A組未予抗菌藥物治療;B組予觀察,隔日檢測PCT,其中40例(55.6%) PCT>0.25μg/L者應用抗菌藥物治療病情好轉,32例(44.4%)<0.25μg/L者未應用抗菌藥物;C組予抗菌藥物治療,其中30例(23.1%)咳嗽、咳痰、呼吸睏難未好轉,更改抗菌藥物治療,最終122例預後較好,6例轉上級醫院,2例分彆在住院第5、6天死亡。結論 COPD急性加重患者PCT水平升高者炎性反應及病情嚴重,基層醫院可依據PCT水平判斷是否存在炎性反應及病情程度,可以將PCT水平作為選用、更改抗菌藥物或評估抗菌藥物療效的參攷工具。
목적:탐토강개소원(PCT)수평검측대만성조새성폐질병(COPD)급성가중환자선용항균약물적지도개치,위COPD급성가중환자선용항균약물제공삼고。방법선취2012년1월—2014년2월재려수시련도구인민의원내과、급진종합과인COPD급성가중입원환자250례,입원후립즉검사PCT。안조PCT수평분위3조,A조( n=48):입원PCT<0.10μg/L,불여항균약물;B조(n=72):발병시간<6 h내PCT<0.10μg/L혹입원PCT위0.10~0.25μg/L,여관찰,격일검측PCT,약격일PCT>0.25μg/L,치료조시동C조;C조( n=130):입원PCT>0.25μg/L,여항균약물치료,동시련속감측PCT,매천하강폭도≥30%설명항감염치료유효,PCT정상후정용항균약물;여과PCT하강폭도<30%,혹지속승고칙조정항균치료방안,병매일검측PCT。대비분석3조환자적림상자료、실험실검사지표급예후。결과3조환자적병사、림상증상、병정정도급실험실검사지표비교,차이균유통계학의의(P<0.05)。A조미여항균약물치료;B조여관찰,격일검측PCT,기중40례(55.6%) PCT>0.25μg/L자응용항균약물치료병정호전,32례(44.4%)<0.25μg/L자미응용항균약물;C조여항균약물치료,기중30례(23.1%)해수、해담、호흡곤난미호전,경개항균약물치료,최종122례예후교호,6례전상급의원,2례분별재주원제5、6천사망。결론 COPD급성가중환자PCT수평승고자염성반응급병정엄중,기층의원가의거PCT수평판단시부존재염성반응급병정정도,가이장PCT수평작위선용、경개항균약물혹평고항균약물료효적삼고공구。
Objective To investigate the guidance values of procalcitonin( PCT)in choosing antimicrobial drugs in a-cute exacerbation of elderly COPD. Methods From January 2012 to February 2014,in Liandu People Hospital,250 acute COPD patients had PCT after admission were divided into groups A(n=48,given PCT<0. 10μg/L without antibacterials at ad-mission),B(n=72,PCT<0. 1 μg/L within 6 h of onset or 0. 10-0. 25 μg/L at admission,PCT determined Alt. dieb;u-sing antibacterials if PCT>0. 25 μg/L Alt. dieb until normal PCT or adjusting antibiotic therapy),C( n=130,PCT>0. 25μg/L,using antibacterials if PCT>0. 25 μg/L Alt. dieb until normal PCT or adjusting antibiotic therapy). The indicators and results of laboratory examinations and prognosis were analyzed comparatively. Results There was significant difference in medi-cal history,clinical symptom,illness degree and indicators of laboratory examination between 3 groups( P<0. 05 ). Group A were not given antibacterials;in group B PCT detected Alt. dieb,40 patients with PCT>0. 25 μg/L improved after antibiotic therapy(55. 6%),32 with PCT<0. 25 μg/L were not given antibiotic therapy(45. 7%);in group C,antibiotic therapy were given,30 changed antibiotic therapy due cough,sputum,dyspnea with improvement,122 had good prognosis,6 transferred to high-level hospitals,2 died in days 5,6 after admission. Conclusion The acute COPD patients with high PCT level have in-flammatory response and are in serious condition. Primary hospitals can judge the existence of inflammatory response and disease severity according to PCT levels and take PCT as a reference tool for choosing,changing or evaluating the effects of antibacterial drugs.